Drug Type Small molecule drug |
Synonyms vanitaracin A |
Target |
Mechanism NTCP inhibitors(Sodium/bile acid cotransporter inhibitors), Hepatitis B virus inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H34O7 |
InChIKeyLCCGEVUWWBLMGC-HLNZEAKCSA-N |
CAS Registry1807458-87-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis D | Preclinical | JP | 05 Nov 2015 | |
Hepatitis B | Preclinical | JP | 01 Oct 2015 |